Drug-Resistant Tuberculosis in Bulgaria
Author Information
Author(s): Valcheva Violeta, Mokrousov Igor, Narvskaya Olga, Rastogi Nalin, Markova Nadya
Primary Institution: The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences
Hypothesis
The study evaluates fast molecular methods to detect drug-resistant tuberculosis and the distribution of resistant properties in different clonal lineages of M. tuberculosis in Bulgaria versus its neighbors.
Conclusion
The M. tuberculosis population in Bulgaria has several specific lineages, and certain mutations can help quickly identify drug-resistant strains.
Supporting Evidence
- The rate of multidrug-resistant tuberculosis among newly diagnosed patients in Bulgaria is estimated to be 10.7%.
- Mutations in rpoB531 were found in 65% of RIF-resistant strains.
- Mutations in katG315 and inhA -15 were detected in 50% of INH-resistant strains.
- 63% of EMB-resistant strains had the embB306 mutation.
Takeaway
This study looks at how to find drug-resistant tuberculosis quickly in Bulgaria, which has its own unique strains.
Methodology
Different typing methods were used to study drug-resistant and susceptible M. tuberculosis strains from newly diagnosed patients.
Limitations
The results for INH resistance are complex and more genes should be studied.
Want to read the original?
Access the complete publication on the publisher's website